Conference
Combination Antithrombotic Therapy for Reduction of Recurrent Ischemic Stroke in Intracranial Atherosclerotic Disease
Abstract
BACKGROUND: Stroke secondary to intracranial atherosclerotic disease (ICAD) is associated with high recurrence risk despite currently available secondary prevention strategies. In patients with systemic atherosclerosis, a significant reduction of stroke risk with no increase in intracranial or fatal hemorrhage was seen when rivaroxaban 2.5 mg twice daily was added to aspirin. However, there are no trials in ICAD using this combination. To …
Authors
Perera KS; Sharma MA; Eikelboom JW; Ng KKH; Field TS; Buck BH; Hill MD; Stotts G; Casaubon LK; Mandzia J
Volume
56
Pagination
pp. 380-389
Publisher
Wolters Kluwer
Publication Date
February 2025
DOI
10.1161/strokeaha.124.047715
Conference proceedings
Stroke
Issue
2
ISSN
0039-2499